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Integrin a2b1 Is Required for Regulation of Murine
Wound Angiogenesis but Is Dispensable
for Reepithelialization
Manon C. Zweers1, Jeffrey M. Davidson2,3,4, Ambra Pozzi2,3,4, Ralf Hallinger1, Katharina Janz5,
Fabio Quondamatteo5, Barbara Leutgeb1, Thomas Krieg1 and Beate Eckes1
The a2b1 integrin functions as the major receptor for collagen type I on a large number of different cell types,
including keratinocytes, fibroblasts, endothelial cells, and a variety of inflammatory cells. Recently, we
demonstrated that adhesion of keratinocytes to collagen critically depends on a2b1, whereas fibroblasts can
partly compensate for loss of a2b1 in simple adhesion to collagen. However, in three-dimensional collagen
matrices, a2b1-null fibroblasts are hampered in generating mechanical forces. These data suggested a pivotal
role for a2b1 during wound healing in vivo. Unexpectedly, reepithelialization of excisional wounds of a2b1-null
mice was not impaired, indicating that keratinocytes do not require adhesion to or migration on collagen for
wound closure. Whereas wound contraction and myofibroblast differentiation were similar, wound tensile
strain was reduced in a2b1-null mice, suggesting subtle changes in organization of the extracellular matrix. In
addition, we observed reduced influx of mast cells into the granulation tissue, whereas infiltration of other
inflammatory cells was not impaired. Interestingly, ablation of a2b1 resulted in strong enhancement of
neovascularization of granulation tissue and sponge implants. Both ultrastructurally and functionally, these new
blood vessels appeared intact. In conclusion, our data show unique and overlapping functions of a2b1 integrin
during murine cutaneous wound healing.
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INTRODUCTION
a2b1 integrin is one of the four integrin receptors that
recognize and bind native collagens with high affinity
(Gullberg and Lundgren-Akerlund, 2002; White et al., 2004).
In addition to mediating adhesion of many cell types,
a2b1 has been implicated in cell migration (Scharffetter-
Kochanek et al., 1992; Grzesiak and Pierschbacher, 1995;
Werr et al., 2000; Klekotka et al., 2001), generation of
mechanical forces (Zhang et al., 2006), and contraction of
collagen lattices (Klein et al., 1991; Schiro et al., 1991;
Langholz et al., 1995), induction and activation of matrix
metalloproteinases (MMPs) (Dumin et al., 2001; Zigrino
et al., 2001), inflammatory reactions (De Fougerolles et al.,
2000; Edelson et al., 2004), epithelial branching morpho-
genesis (Zutter et al., 1995; Chen et al., 2002), angiogenesis
(Senger et al., 2002), and collagen fibrillogenesis (Velling
et al., 2002; Li et al., 2003). These properties have been
demonstrated using antibodies specific for the distinct
integrins and/or a2b1 integrin-deficient mice. Some of these
functions seem to be shared with other collagen-binding
integrins, for example, with a1b1 for angiogenic sprouting
and mounting of an inflammatory response, or with a11b1 for
collagen fibril formation. Other functions are specific to
a2b1, such as MMP induction and branching morphogenesis.
Soon after the initial detection of a2b1 on T cells (Hemler
et al., 1985), expression of a2b1 was noted on platelets. Here,
it was suggested to play a critical role in platelet–collagen
interactions that result in formation of the hemostatic plug,
thus preventing blood loss following tissue trauma (Staatz
et al., 1989).
Two mouse models lacking a2b1 expression in all cells of
the organism have been generated independently (Chen
et al., 2002; Holtkotter et al., 2002). Both mutant mouse
strains clearly demonstrate that development and fertility are
not impaired by ablation of the a2 subunit. This surprising
result stimulated the analysis of defined cellular functions in
vitro. In addition, platelet functions were specifically
challenged in injury models in vivo. While no extended
bleeding was observed following injury of the a2-null tail,
aggregation of a2-null platelets in response to native collagen
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was delayed in vitro (Chen et al., 2002; Holtkotter et al.,
2002; Gruner et al., 2003; He et al., 2003). By contrast,
massive bleeding occurred in mice both lacking the non-
integrin platelet collagen receptor GPVI and haploinsufficient
or deficient in a2b1 (Gruner et al., 2004), indicating
redundant functions in platelet collagen receptors GPVI and
a2b1 (Nieswandt et al., 2001; Nieswandt and Watson, 2003).
Similarly, in vitro assays applied to test rigorously a2-null
fibroblast functions demonstrated partial rescue of a2b1
deficiency by other collagen receptors. Fibroblasts in mono-
layer culture express low levels of a2b1 and a1b1 but
abundant a11b1. Cultured fibroblasts isolated from the skin of
a2-null mice adhered less well to collagen I than wild-type
controls (Zhang et al., 2006). Moreover, dynamic functions
such as focal adhesion turnover in fibroblasts adhering to
collagen I, generation of tractional forces and contraction of
collagen lattices were impaired (Zhang et al., 2006). In
contrast to platelets and fibroblasts, keratinocytes express
a2b1 as their sole collagen receptor. Accordingly, keratino-
cytes isolated from a2-null skin failed to adhere to collagens,
while adhering normally to laminins (Zhang et al., 2006) and
fibronectin.
Restoration of tissue architecture and function critically
involves all the functions of platelets, fibroblasts, and
keratinocytes described above, in addition to functions
executed by T cells, mast cells, neutrophils, macrophages,
and endothelial cells, all of which also express a2b1. Healing
of full-thickness skin wounds was therefore studied in a2b1-
deficient mice to uncover potential deficits arising from
dysfunction of defined cell types lacking a2b1 and to identify
compensatory mechanisms in the context of the whole
animal. Here we show that unexpectedly, reepithelialization
proceeds normally. Further, we detected alterations in
inflammatory cell infiltration, but no changes in the kinetics
of granulation tissue formation or contraction by myofibro-
blasts. In the granulation tissue there was an increase in
wound angiogenesis.
RESULTS
Macroscopically normal wound closure in a2 integrin-deficient
mice
To determine how loss of a2 integrin affects cell behavior in a
pathophysiological situation, two full-thickness excisional
wounds were made in the dorsal skin of a2 integrin-deficient
and control mice. Wound appearance and size was followed
macroscopically over 10 days. No alterations in appearance
or macroscopic wound closure were observed between a2-
integrin null mice and wild type. Integrin a2b1-null wounds
showed a normal eschar, indicating no alterations in platelet
and neutrophils infiltration and function. The absence of a2
integrin did not affect the rate of wound closure (Figure 1).
Reepithelialization and differentiation is not impaired in a2
integrin-deficient mice
In wounded skin of control mice, a2 integrin expression was
detected in basal keratinocytes, and staining was more
intense towards and on the migrating tip of the epidermis.
As expected, no a2 integrin was detected in a2 integrin-null
mice (Figure 2a). Despite strong expression of a2 integrin in
control wound keratinocytes, no gross differences were
observed in reepithelialization of wounds of a2 integrin-
deficient mice in comparison to controls at the histological
level (Figure 2a). The morphology of the epithelial tongue
appeared grossly similar. As a measure of keratinocyte
migration and proliferation, we determined the distance
between the migrating epidermal tips and the area of the
epithelial tongues. No significant alterations were observed
in the rate of reepithelialization of a2 integrin-deficient
wounds (Figure 2b and c). To determine whether the lack of
a2 integrin subunit is compensated for by other collagen
binding integrins, we studied the expression of a11b1 integrin
using immunofluorescence. No expression of a11b1 was
observed in the epithelial tongue of either control or a2-null
wounds (not shown), indicating lack of compensatory, de
novo expression of a11b1. Expression of a3b1 integrin, the
receptor for laminin-5 on migrating keratinocytes, was not
altered in a2-deficient wounds (Figure 2a). In addition,
ablation of a2 integrin did not result in perturbed expression
of the basement membrane proteins laminin-5 (Figure 2a)
and collagen type IV (not shown).
Degradation of the extracellular matrix is thought to be
important for the migration of keratinocytes towards the open
wound area, and a2-integrin has been implicated in
regulating the activity of collagenases (Pilcher et al., 1997;
Dumin et al., 2001). In situ zymography performed on 3-day
wounds showed gelatinolytic activity at the migrating edge of
the wounded epidermis, suggesting activation of MMP-2 and/
or MMP-9. However, distribution of MMP activity was similar
in a2 integrin-null and control mice (data not shown).
At 7-day postwounding, both wounds of control and a2
integrin-deficient mice were completely reepithelialized, a
process that requires keratinocyte migration and proliferation.
This result could be due to increased keratinocyte prolifera-
tion, which compensates for impaired migration due to
the absence of a2-integrin. Ki67 staining, however, indicated
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Figure 1. No macroscopic difference in wound closure between a2
integrin-null and control mice. Wounds were photographed at the indicated
time points postwounding (left) and wound closure was measured as
% of initial wound size (right). White bars indicate control, black bars
indicate a2-null wounds. For each time point at least 16 wounds/genotype
were measured. 1, 3, and 7¼ number of days postinjury.
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that proliferation of keratinocytes was slightly, albeit not
significantly, decreased (14 Ki67-positive keratinocytes/mm
basal layer in a2 integrin-null mice compared to 22 in control
mice; P¼0.3). This correlated with a corresponding decrease
in hyperproliferative area of the epidermis (0.11 mm2 in
a2b1-null vs 0.15 mm2 in control mice, P¼0.07). The
expression pattern of keratin-10 and loricrin appeared
normal. Keratin-10 expression was observed in all suprabasal
layers, whereas loricrin was only expressed in the granular
cell layer (Figure 3).
Wound contraction is similar in a2 integrin deficient mice and
controls
Several studies have shown that a2 integrin activity is pivotal
for reorganization and contraction of a collagen matrix (Klein
et al., 1991; Schiro et al., 1991; Langholz et al., 1995;
Phillips and Bonassar, 2005; Zhang et al., 2006) suggesting
an important role for a2 integrin during wound contraction.
Surprisingly, wounds of a2 integrin-deficient mice contracted
at a similar rate as control wounds (Figure 4a). During wound
healing, fibroblasts differentiate into myofibroblasts, the
specialized cell type responsible for contraction of the
granulation tissue (for a review see Tomasek et al., 2002).
To elucidate whether transdifferentiation of fibroblasts into
myofibroblasts was dependent on a2b1 integrin, we studied
the expression of a-smooth muscle actin (a-SMA), as a marker
for myofibroblasts. In 5-day-old wounds, myofibroblasts were
mainly seen at the wound edges, in 7-day-old wounds,
myofibroblasts were present throughout the granulation tissue
in both a2 integrin-null and control wounds. At 10 days
postinjury, myofibroblasts were mostly localized subepi-
dermally. The expression pattern of a-SMA was not altered
in a2 integrin-deficient mice (Figure 4c). In addition, Western
blots showed no difference in the amount of a-SMA in wound
lysates (Figure 4b).
Expression of collagen-binding integrins in skin and wounds
To study whether loss of a2 integrin function may be
compensated for by the collagen-binding integrins a1b1 or
a11b1, we studied their expression levels in cultured primary
skin cells, epidermis, dermis and wounds. In epidermis and
cultured keratinocytes, no a1- and a11-integrin expression
could be detected, whereas expression of a2 integrin was
only seen in wild type (Figure 5a). Similar expression of a1
integrin was detected in dermis and cultured fibroblasts of
wild type and a2-null mice. Whereas strong expression of a2
integrin was observed in dermis of wild-type animals, fibro-
blasts obtained thereof showed only moderate expression of
a2-integrin (Figure 5a). In a2 integrin-null mice, a11 integrin
mRNA was slightly reduced in dermis and 3-day wounds,
whereas a11 integrin protein levels were comparable with
wild-type mice. The expression of a1 integrin was increased
in a2 integrin-deficient mice as compared to controls at 3 and
7 days postwounding (Figure 5b). Western blot showed
similar expression of a11- and b1-integrin in a2 integrin-null
mice and controls, and b1-integrin expression decreased with
time from 3 days postinjury. Integrin a2 was undetectable in
a2 integrin-null mice (Figure 5c).
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Figure 2. Reepithelialization is not altered in a2 integrin-null wounds as
compared to controls at 3 days postinjury. (a) Haematoxylin and eosin
staining shows a comparable epithelial tongue in control (WT) and a2
integrin-null (a2/) wounds. Integrin a2 is expressed in the basal layer of
migrating keratinocytes in control, whereas its expression is absent in a2
integrin null mice. Keratin 14 (K14) shows a similar expression pattern in both
genotypes. (a) No difference in expression pattern of integrin a3 and its
substrate laminin 5 (lam) can be seen in a2 integrin-deficient and control
wounds. (b) Distance between the two epithelial tongues migrating in from
the left and right wound margin and the (c) area of the hyperproliferative
epidermis are similar in a2 integrin-null and control wounds. (&)¼ control,
(’)¼ a2 null. Eight wounds were measured per genotype. Bar¼ 100mm.
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Reduced mast cell infiltration
Since a2 integrin is expressed on a variety of cells of the
immune system, including neutrophils, a subset of T-lympho-
cytes and mast cells, we studied the inflammatory response in
wounds of a2 integrin-null mice and controls at 3 days
postinjury. Whereas infiltration of macrophages and neutro-
phils appeared the same, infiltration of mast cells into the
wound bed was strongly diminished (45 mast cells/mm2 in
control vs 24 mast cells/mm2 in a2 integrin-null mice,
P¼0.02; Figure 6). Mast cells accumulated at the border of
the loose connective tissue and normal dermis, and were less
abundant in the wound middle of both a2b1-null and control
mice. Since degranulation of peritoneal mast cells in a model
of acute peritonitis was shown to be delayed in a2-integrin-
deficient mice (Edelson et al., 2004), we determined the
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Figure 3. Normal formation and differentiation of neo-epidermis in absence
of a2 integrin. (a) Haematoxylin and eosin staining at 7 days postinjury shows
closed wounds in both control (wt) and a2 integrin null (a2/) mice.
Staining for suprabasal differentiation markers keratin 10 (K10) and
loricrin (lor) and Ki67 is similar in a2 integrin-null and control wounds.
(b) Proliferation (Ki67-staining) of keratinocytes in 7-day wounds
is shown. (c) Area of hyperproliferative epidermis (n¼4/genotype)
is shown. Bar¼ 100mm.
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Figure 4. Granulation tissue formation is not impaired in a2 integrin-null
wounds. (a) Wound contraction as measured by distance between the two cut
margins of the panniculus muscle is shown (n¼ 5/genotype). (b) Western blot
shows declining amounts of a-SMA with time, but no differences between
a2 integrin-null and control wounds. (c) At 5 and 7 days postinjury, the
distribution of a-smooth muscle actin (a-SMA) is similar in a2 integrin-null
(right) and control (left) wounds. Arrows indicate the leading edge of the
migrating tip in 5-day wounds and middle of granulation tissue in 7-day
wounds. Bar¼ 100mm. Closed symbols a2 integrin null, open symbols
control.
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percentage of degranulated mast cells in the wounds of our
mice. However, we observed no significant difference in
degranulation (23% in control vs 38% in a2 integrin-null
mice, P¼0.4).
Scar deformability is reduced in a2 integrin deficient mice
a2 integrin has been shown to participate in collagen
fibrillogenesis (Velling et al., 2002; Li et al., 2003). We
studied the consequences of loss of a2 integrin on collagen
fibril morphology in wounds. Using immunofluorescence,
deposition of collagen type I was observed below the
dermal–epidermal junction and throughout the dermis at 10
days postwounding in both a2 integrin-deficient and control
wounds (Figure 7a). Ultrastructurally, collagen fibrils of
a2-deficient mice did not show any pathological aspects in
16-day incisional wounds (Figure 7b). Accordingly, tensile
strength, that is, the force required to break skin, was not
altered in 16-day incisional wounds. However, tensile strain,
a measure of tissue deformability, was significantly reduced
in a2 integrin-null wounds as compared to wild-type wounds
(18% vs 23%, Po0.05; Figure 7c). The collagen content of a2
integrin-deficient wounds (40%), as measured by amino-acid
analysis, was equivalent to that of the wild-type tissue.
Increased angiogenesis in a2 integrin deficient mice
Angiogenesis, the formation of new blood vessels from pre-
existing vasculature, requires the coordinated process of
endothelial cell migration, proliferation, and differentiation,
processes for all of which integrins have been shown to be
essential. Previous experiments using blocking antibodies
have demonstrated an important role for a2b1 integrin in
endothelial cell migration and chemotaxis towards VEGF and
on collagen type I in vitro, and a potent synergistic effect of
antibodies blocking a1b1 and a2b1 integrin in reducing
VEGF-driven angiogenesis in skin in vivo (Senger et al.,
2002). Interestingly, we found increased angiogenesis in
wounds of a2 integrin null mice. While the number of and
area occupied by vessels (as determined by PECAM-1/CD31
staining; Figure 8a and b) were equal in a2-null and control
wounds at 5-days postinjury, we observed a significant
increase in area occupied by vessels at 10-day post-
wounding (Figure 8b). To determine whether these additional
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Figure 5. Expression of collagen binding integrins. Relative expression levels
of collagen binding integrin subunits were determined using semiquantitative
reverse transcriptase-PCR in epidermis (Epi), dermis (Der), and cultured
keratinocytes (KC) and (a) fibroblasts (Fib) and (b) in wounded skin at 3 (3D)
and 7 days (7D) post-injury from integrin a2-deficient and wild-type
littermates (n¼3 per group). (c) Western blotting shows similar expression
of b1 and a11 integrin in a2 null and control wounds, whereas a2 integrin
is completely absent from a2 integrin deficient wounds (n¼ 3/group).
þ ; control mice, ; a2 integrin null mice.
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Figure 6. Reduced infiltration of mast cells in a2 integrin null wounds at
3 days postwounding. (a) Mast cells (MC) were stained with chloracetetate
stain and macrophages (MF) were visualized with F4/80 antibody.
(b) Number of mast cells per mm2 is significantly reduced in a2 integrin
null-(a2/) versus control (wt) wounds (P¼ 0.02, n¼ 5/genotype).
Bar¼100 mm. *Po0.05.
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vessels were intact and mature, we stained for markers of
pericytes, the mural cells enveloping microvessels (Armulik
et al., 2005). Vessels stained positively for a-SMA and desmin
in both control and a2 integrin-null wounds at 7- and 10-day
postinjury (data not shown). In addition, tight junctions
between neighboring endothelial cells in a2 integrin-defi-
cient vessels did not differ from control wounds at the
ultrastructural level (Figure 8c).
To clarify whether the observed increase in angiogenesis is
due to alterations in the expression of angiogenic factors,
wound lysates of 7- and 10-day wounds were collected and
hybridized with a protein array. Overall, expression levels of
all factors were low in this assay. No obvious differences
were observed in expression levels of a variety of angiogenic
factors, including IL-1a, IL-9, IL-12, platelet factor 4, tissue
inhibitor of MMPs-1 and monocyte chemoattractant protein-
1 (data not shown). The distribution of VEGF-receptor 2 in
wounds, as determined by immunohistochemistry, was not
changed (Figure 8a).
The increased angiogenesis observed in wounds of a2
integrin-null mice was further confirmed using implanted
sponges. Macroscopically, sponges implanted for 16 days
into a2 integrin-null mice appeared more vascularized
(Figure 9a). Microscopically, a significant increase in
vascularity (as measured by rhodamine-dextran positive area)
was seen in implanted inert sponges after 16 days (6% in wild
type vs 15% in a2 integrin-null mice, Po0.01) representing
augmented angiogenesis (Figure 9b and c). The vessels
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Figure 7. Collagen deposition in the absence of a2 integrin.
(a) Immunostaining of sections of wild type and a2 integrin null wounds with
collagen type I antibody shows deposition in newly formed dermis in both.
(b) Electron microscopy of skin at 16 days postwounding shows similar
collagen fiber cross-sections (upper panel) and collagen fibrils showed
typical cross-striated pattern (lower panel) in a2-null and wild-type
wounds. Biomechanical properties of 16D incisional wounds were
measured using a tensiometer. (c) Tensile strain was significantly reduced
in a2 null mice as compared to control (n¼ 10/group, *Po0.05).
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Figure 8. Increased angiogenesis in a2 integrin-null wounds. (a) PECAM-1
(CD31) defines new blood vessels in a2 integrin-null and control wounds at
7 and 10 days postinjury. VEGF-R2 is expressed on newly formed vessels.
Bar¼100 mm. (b) The area of CD31 positive staining is shown in. Data are
shown as mean7SEM (X5 animals per genotype/time point). Black bars¼ a2
null, white bars¼wild type. (c) Electron microscopy shows normal tight
junctions (arrow) in a2-integrin null wounds 16 days post-wounding.
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sprouting into the sponges appeared to be functional, since
fluorescent dye was retained within the vascular lumen.
DISCUSSION
Following cutaneous injury, a coordinated series of events is
initiated to mediate the repair process. This includes the
formation of a provisional matrix over and through which
cells migrate, the infiltration of inflammatory cells that are a
source of proinflammatory cytokines, the migration and
proliferation of keratinocytes to cover the denuded dermis
and the formation of new blood vessels (Martin, 1997;
Werner and Grose, 2003). Although there are considerable
differences between mouse and human skin, mice with
specific genetic alterations have been proven to be valuable
model systems to study the involved mechanisms. The
collagen-binding integrin a2b1 is expressed on virtually
every cell type present during the wound healing process,
for example, inflammatory cells, keratinocytes, fibroblasts,
and endothelial cells. Based on a variety of in vitro and in
vivo studies, a2b1 integrin-mediated cell collagen contacts
have been suggested to be critical for various aspects of
wound healing, including keratinocyte migration, granulation
tissue contraction, wound angiogenesis, and scar maturation
(Yamada et al., 1996; Nguyen et al., 2000; Senger et al.,
2002). In this study, we demonstrate that a2b1 integrin has
important but unexpected roles in murine cutaneous tissue
repair.
Normal reepithelialization in the absence of a2b1 integrin
Migrating keratinocytes at the wound edge express several
integrins, including collagen-binding a2b1, laminin-binding
a3b1, fibronectin-binding avb6 and a5b1, a9b1 recognizing
tenascin-C, and the vitronectin receptor avb5. It has been
postulated that reepithelialization requires the presence of
a2b1 expression on migrating keratinocytes to allow them to
move off the basement membrane and adhere to and migrate
over collagen type I of the injured dermis (Pilcher et al.,
1997; Hodivala-Dilke et al., 1998; Goldfinger et al., 1999;
Nguyen et al., 2000; Grose et al., 2002). Here we provide
evidence that a2b1 is not pivotal for reepithelialization of
murine wounds, since wound closure takes place in the
absence of a2b1 integrin. We found no compensatory
expression of a1b1 or a11b1 in the epidermis or cultured
keratinocytes of a2-null mice. We believe that the observed
increased a1 mRNA expression in 3- and 7-day wounds of
a2-null mice derives from leukocytes, fibroblasts, and
endothelial cells, rather than from keratinocytes. The expres-
sion of the laminin receptor a3b1 in the migrating tip showed
a similar pattern in a2b1-null as in control mice. Although
a3b1 is generally believed to be a laminin-5 receptor (Carter
et al., 1991; Aumailley and Krieg, 1996), it has been
suggested that a3b1 integrin could function as a collagen
receptor (Yamamoto and Yamamoto, 1994; Ellerbroek et al.,
2001), thereby potentially replacing a2b1 integrin function.
However, this is not likely to be the case, since the absence of
a2b1 integrin virtually abolishes adhesion and migration of
keratinocytes on collagen type I and IV in vitro (Zhang et al.,
2006). This set of observations suggests that keratinocytes do
not migrate on collagen during wound healing, but rather on
other provisional matrix components. Although a2b1 integrin
expression clearly is required for keratinocyte–collagen
interaction, the function of a2b1 expression on the lateral
site of keratinocytes remains unknown. It may be involved in
direct cell–cell contact or it might use a thus far unknown
ligand. Unlike wounds in mice lacking all b1-integrins (Grose
et al., 2002), deposition of laminin-5 and collagen type IV
was not affected in a2b1 integrin deficient wounds, indicat-
ing that correct deposition of these extracellular matrix
components does not depend on a2b1 integrin. Taken
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Figure 9. Increased vascularization of implanted sponges in a2 integrin-
deficient mice at 16 days. (a) Gross images of polyvinyl acetal CF-50 sponges
implanted for 16 days into wild type and integrin a2-null mice. (b) At
10 minutes prior to killing mice were injected intravenously with 50 ml of
rhodamine-dextran. Sponges were then removed and placed under a
fluorescence microscope to visualize vascularization. (c) Vascularity within
sponges was determined by calculating the area occupied by rhodamine-
positive structures per microscopic field as described under ‘‘Materials and
Methods’’. Values indicate the mean7SD calculated for 10 images.
Vascularity in a2-null mice was significantly increased (Po0.05).
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together, our results suggest that contact with collagen of the
injured dermis is not essential for reepithelialization of
murine wounds.
Scar formation in a2b1 null mice
In the early phases of wound healing, fibroblasts are
stimulated to migrate into the provisional matrix by cytokines
released from the inflammatory cells in the wound bed.
There, a portion of these mesenchymal cells differentiate into
myofibroblasts and accelerate wound closure by deposition
of a collagen matrix and subsequent contraction of the
wound. Here, we demonstrated that a2b1 integrin is not
required for migration of fibroblasts into the granulation
tissue or the differentiation of fibroblasts into myofibroblasts.
Since fibroblasts also express collagen-binding integrins a1b1
and a11b1 (Tiger et al., 2001; Popova et al., 2004), it is likely
that these receptors compensate to permit the migration and
contractility of a2b1-null fibroblasts. Indeed, we have
recently shown normal migration of a2b1-null fibroblasts
on collagen type I in vitro (Zhang et al., 2006), indicating
compensatory mechanisms.
Various studies have suggested that the different collagen
binding integrins can be assigned distinct functions with
respect to organization of collagen fibrils under in vitro
conditions: whereas a1b1 integrin mediates feedback regula-
tion of collagen synthesis, a2b1 integrin mediates induction
of collagenase I/MMP-1 (Langholz et al., 1995; Riikonen
et al., 1995). Hence, the absence of a2b1 could result in
decreased degradation of the collagen matrix, potentially
leading to increased collagen content. However, our data
demonstrate that collagen content of wounds is not altered. In
contrast, a1b1-null mice showed enhanced collagen synth-
esis, but reduced tensile strength of skin (Gardner et al.,
1999). The balance between a1b1 and a2b1 may influence
the equilibrium between collagen degradation and synthesis,
but the biomechanical properties of wounds likely depend on
a number of additional factors.
Besides its role in activation of collagenases, a2b1 has
been implicated in the regulation of collagen fibrillogenesis
(Velling et al., 2002; Li et al., 2003; Jokinen et al., 2004).
Aggregation of individual collagen molecules into fibrils is in
part a self-assembly process occurring in the extracellular
space; however, the details of collagen fibrillogenesis are still
incompletely understood. Tissue-specific arrangement and
organization certainly indicate that fibrillogenesis is very
complex. The processing of procollagen peptides, the relative
abundance of types I, III, and V collagen, interactions with
various extracellular matrix proteins, including small leucine-
rich proteoglycans and fibril-associated collagens with
interrupted triple helices collagens can affect the assembly
of collagen fibrils (Ameye and Young, 2002; Canty and
Kadler, 2005). a2b1 may also guide pericellular fibrillo-
genesis (Jokinen et al., 2004), and neutralizing antibodies to
a2b1 inhibited fibril assembly in cultured smooth muscle
cells (Li et al., 2003). Here, we demonstrated that ablation of
a2b1 did not cause major alterations in collagen content nor
collagen fibril morphology in the scar tissue. However,
tensile strain of the scars was decreased, indicating that the
tissue is less deformable. Subtle changes in collagen fibril
architecture or metabolism could at least partially explain the
reduced tensile strain of the wound.
Abnormal inflammatory response in a2b1 integrin null wounds
a2b1 is expressed on a variety of immune cells and has been
implicated to play a role during immune responses (De
Fougerolles et al., 2000; Werr et al., 2000; Edelson et al.,
2004). A recent study has shown the expression of a2b1
integrin on activated peritoneal mast cells (Edelson et al.,
2004), suggesting that connective tissue mast cells express
a2b1. We found no differences in the infiltration of
polymorphonuclear neutrophils and macrophages into the
wound bed, suggesting that the expression of a2b1 is not
essential for migration of these inflammatory cells into the
wound area. This is supported by a study showing that
adherence of macrophages to collagen depends on macro-
phage scavenger receptors rather than on b1-integrins
(Gowen et al., 2000). In contrast, we found a significant
decrease in mast cell numbers in wounds of a2b1-null mice,
indicating that migration of mast cells into the wound bed is
limited by the expression of a2b1 integrin. Unlike fibroblasts,
mast cells do not appear to express collagen-binding integrins
that could compensate for lack of a2b1. This finding agrees
with a recent report that peritoneal mast cells derived from
a2b1 knockout mice fail to adhere to collagen (Edelson et al.,
2004). Reduced numbers of mast cells did not correlate with
reduced angiogenesis, as may have been anticipated, since
mast cells could be a source of VEGF. Apparently, other cell
types, such as keratinocytes, supply sufficient VEGF.
The absence of a2b1 causes enhanced neovascularization
Data obtained using integrin blocking antibodies in vivo and
in vitro have pointed towards a role for a2b1 in promoting
VEGF-driven signaling, endothelial cell migration, and tumor
angiogenesis (Senger et al., 1997; Senger et al., 2002; Hong
et al., 2004). Unexpectedly, we observed that ablation of
a2b1 resulted in a strong enhancement of angiogenesis in
cutaneous wounds and implanted sponges. Our observation
contrasts with studies using integrin-blocking antibodies that
describe a stimulatory role for a2b1 integrin in lymphatic
vessel formation and angiogenesis (Senger et al., 1997, 2002;
Hong et al., 2004). Indeed, several studies using integrin
antagonists –which act by engaging the receptor –have failed
to be reflected in the phenotype of the respective integrin-null
mice. For example, blocking avb3 and avb5 antibodies
inhibit angiogenesis (Brooks et al., 1994, 1995; Friedlander
et al., 1995), while genetic ablation of b3 and b5 integrins
does not result in decreased angiogenesis (Hynes, 2002;
Reynolds et al., 2002, 2005). This discrepancy could be due
to nonspecific effects of these antibodies on cell behavior or
trans-dominant inhibition of proangiogenic integrins, as
proposed by Diaz-Gonzalez et al. (1996).
There are several potential explanations as to why abla-
tion of a2b1 integrin causes increased neovascularization in
wounds. First, the absence of a2b1 could shift the balance of
collagen receptor-integrin signaling towards enhanced a1b1
signaling in endothelial cells. Integrin a1b1 is proangiogenic,
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as mice lacking this collagen-binding receptor show reduced
tumor angiogenesis due to augmented MMP-dependent
angiostatin levels (Pozzi et al., 2000). We speculate that
lack of a1b1 tilts the balance in favor of a2b1, an
antiangiogenic receptor, thus resulting in reduced angiogen-
esis. Enhanced a1b1 signaling would prevail in a2-null
wounds, thus decreasing MMP activity and consequent
generation of antiangiogenic products, favoring neovascular-
ization.
Another possibility could be that in the absence of a2b1,
endorepellin cannot exert its function. Endorepellin is an
antiangiogenic mediator derived from the C-terminal domain
of the heparan sulfate proteoglycan perlecan (Mongiat et al.,
2003). Interestingly, endorepellin was shown to inhibit angio-
genesis by inducing disassembly of the actin cytoskeleton and
focal contacts. Endorepellin was shown to use a2b1 integrin
as a receptor (Bix et al., 2004). Further studies must be
performed to elucidate the exact mechanism by which a2b1
integrin controls angiogenesis.
In conclusion, although in vitro studies have been pivotal
to dissect the role of a2b1 integrin on different cell types, a
number of discrepancies arise when one turns to the observed
phenotype in a2b1-null mice. Clearly, in vitro models of
adhesion to and migration on extracellular matrix molecules
do not fully reflect the in vivo situation, where the
extracellular matrix is a complex aggregate of macromole-
cules and growth factors regulating cell function. Blocking
antibodies/reagents may have unanticipated side effects, and
these in vitro experiments should therefore be regarded
cautiously. It is possible that there are overlapping functions
of integrins or unknown mechanisms of compensation in
vivo, which are lacking in vitro. Genetic ablation of several of
these collagen-binding integrins, combined with appropriate
physiological stress to create a rate-limiting deficiency may
be the only way to reveal essential function.
MATERIALS AND METHODS
Integrin a2-deficient mice
The generation of integrin a2-deficient mice has been described
elsewhere (Holtkotter et al., 2002). Animals were backcrossed into
the C57Bl6 background for seven generations. All animals used in
the studies were females between 3 and 5 months of age; age and
sex-matched littermates were used as controls. Animals were housed
in specific-pathogen-free facilities and all animal protocols were
approved by the local veterinary authorities.
Culture of primary fibroblasts and keratinocytes
Primary fibroblasts and keratinocytes were isolated and cultured as
previously described (Zhang et al., 2006). In brief, entire trunk skin
of newborn animals was removed and incubated overnight with
0.1% trypsin, 0.02% EDTA in phosphate-buffered saline (PBS),
followed by mechanical separation of epidermis from dermis.
Fibroblasts were isolated from the dermis following incubation with
400 U/ml of collagenase I (Cell Systems, St Katharinen, Germany)
for 1 h at 371C, and cultured in DMEM (Invitrogen, Karlsruhe,
Germany) containing 10% fetal calf serum (PAA Laboratories, Co¨lbe,
Germany), 2 mM glutamine and antibiotics (Seromed-Biochrom,
Berlin, Germany). The fibroblasts were used between passage
3 and 5 for experiments. Keratinocytes were isolated from the
epidermis according to Rheinwald and Green (1975) with some
modifications (Zhang et al., 2006). Keratinocytes were cultured on
fibronectin-coated (10mg/ml; Sigma) plates together with growth-
arrested 3T3 J2 feeder cells. Cultures were maintained in DMEM/
Ham’s with supplements (see Zhang et al., 2006) at 321C and used
for experiments at passage 2 to 4.
Wounding
Mice were anaesthetized by intraperitoneal injection of ketamine
(10 g/l)/xylazine (8 g/l) solution (10 ml/g body weight) (Pharmacia &
Upjohn, Somerset County, NJ). Two circular full-thickness excisional
wounds of 6 mm in diameter were created at each side of the
scapular region by excising skin and the subcutaneous muscle
panniculus carnosus. Wounds were left uncovered, digitally photo-
graphed at indicated intervals and harvested at 3, 5, 7, 10, and 16
days after wounding. Macroscopic wound closure was determined
using Photoshop software (Adobe, San Jose, CA), and wound size
was expressed as percentage of initial (day 0) wound area.
Alternatively, a full-thickness incisional wound of 2.5 cm crossing
the midline was made on the lower dorsum, left uncovered, and
harvested at 16 days after injury.
The subcutaneous sponge model was used to determine in vivo
angiogenesis (Pozzi et al., 2005). Briefly, sterile polyvinyl acetal
CF-50 round sponges (6 3 mm2, Medtronic Xomed, Jacksonville,
FL) were implanted for 16 days under the ventral skin. At 10 minutes
before killing, mice were injected intravenously with 50 ml of
rhodamine-dextran (Mr 65, 2% in PBS, Sigma) to label blood
vessels, and the sponges were subsequently collected and analyzed
under an epifluorescence microscope. Rhodamine-dextran-positive
structures were imaged, the color images converted to black and
white pictures using Photoshop (Adobe), and processed as described
(Pozzi et al., 2000, 2005). Vascularity within sponges was expressed
as a percentage of area occupied by rhodamine-dextran-positive
structures per microscopic field.
Tissue harvesting
For histological analysis, the complete wounds were removed with a
small margin of surrounding skin; wounds of 3, 5, and 7 days were
bisected. Sponges were removed completely and bisected. Tissue
was either frozen unfixed in optimal cutting temperature compound
(Sakura, Torrance, CA) or fixed for 4 h in 4% paraformaldehyde
solution before paraffin embedding. For electron microscopy studies,
samples were fixed overnight in 3% glutaraldehyde in PBS. For
expression analysis, wounds were excised without margins, and the
tissue was snap-frozen in liquid nitrogen.
Immunohistochemistry and immunofluorescence
Six-micrometer sections were mounted on polylysine-coated slides
and fixed for 8 minutes in ice-cold acetone. Paraffin sections were
deparaffinized and rehydrated, followed by antigen retrieval by
heating the sections in ChemMate target retrieval solution (Dako,
Glostrup, Denmark) at 901C and then incubation with 0.1% trypsin
for 15 minutes at 371C. For general histology, the samples were
stained with haematoxylin and eosin. For immunofluorescence,
sections were blocked with the appropriate normal serum (Dako)
before application of antibodies directed against a-SMA (clone 1A4,
Sigma-Aldrich, St Louis, MO), b1-integrin (9EG7, BD Biosciences,
www.jidonline.org 475
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Heidelberg, Germany), a2-integrin (peptide synthesis, conjugation to
keyhole limpet hemocyanin and immunization were performed at
Innovagen, Lund, Sweden), a3-integrin, a11-integrin, and laminin 5
(kind gifts from respectively Dr DiPersio, Albany, NY; Dr Gullberg,
Bergen, Norway; and Dr Burgeson, Boston, MA), rabbit anti-
collagen type IV (Cedarlane, Hornby, Canada), rabbit anti-keratin-
14 (Covance, Princeton, NJ), rabbit anti-keratin-10 (Covance), rabbit
anti-loricin (Covance), PECAM-1 (MEC13.3, BD Biosciences, Hei-
delberg, Germany) and monoclonal IgG1 mouse anti-desmin
(Dako). The appropriate Alexa 488 nm- or Alexa 594 nm-conjugated
secondary antibodies (Molecular Probes, Eugene, OR) were applied,
sections were counterstained and embedded in mounting medium.
For immunohistochemistry, sections were incubated with primary
antibodies directed against Ki67 (Tec-3, Dako) or F4/80 (Serotec,
Oxford, UK), followed by biotin-conjugated secondary antibodies.
Then, streptavidin horseradish peroxidase was added and amino-
ethylcarbazol was used as chromogenic substrate (Dako). If
necessary, sections were counterstained with Mayer’s haematoxylin
(Sigma). Neutrophils and mast cells were visualized by Giemsa and
chloroacetate esterase staining according to the standard protocols
(Leder, 1979).
Image analysis and morphometry
Images of wound middle and wound edges of 6-mm sections stained
for CD31 were acquired using a Nikon microscope equipped with a
digital camera. Area and number of CD31-positive vessels was
determined semiautomatically using Lucia software (Laboratory
Imaging, Du¨sseldorf, Germany). All measurements were performed
using a  200 magnification.
Numbers of Giemsa-or chloroacetate esterase-positive cells were
counted manually in multiple wound regions and area of this region
was determined using DISKUS software (Hilgers, Ko¨nigswinter,
Germany). Number of Ki67-positive cells was expressed per
micrometer basal layer.
Haematoxylin and eosin stained sections were used to determine
area of hyperproliferative epidermis and distance between the two
migrating epidermal tips were determined using DISKUS software.
Distance between the cut ends of the panniculus carnosus muscle
was used to determine the extent of wound contraction.
In situ zymography
For demonstration of gelatinolytic activity, we followed the
procedure described in Kurschat et al. (2002). Briefly, 6mm cryo-
sections were mounted on gelatin-coated (Sigma) slides and
incubated for 16 h at 371C. Sections were stained with methylene
blue, photographed, and subsequently removed from the slide using
5% SDS in PBS. Slides were stained with Coomassie blue, washed,
and photographed again at the same coordinates.
Electron microscopy
Wounds of four control and four integrin a2-deficient mice were
excised immediately after killing of the mice and fixed in a mixture
of 3% glutaraldehyde and 3% paraformaldehyde in phosphate
buffer. After rinsing, specimens were postfixed in 1% osmium
tetroxyde. The specimens were dehydrated in an ascending series of
ethanol and embedded in Epon. Semithin sections of 1mm were cut
for orientation purposes to select the wounded area and stained with
Richardson’s. Afterwards, ultrathin sections of 90 nm were cut on an
ultramicrotome (Reichert, Bensheim, Germany) and collected in
formvar-coated nickel grids. Sections were then stained with uranyl
acetate and lead citrate. The sections were examined with a LEO 906
E transmission electron microscope (Zeiss, Oberkochen, Germany).
Western immunoblotting
Snap-frozen wounds, lysed keratinocyte- and fibroblast cultures, and
enzymatically separated dermis and epidermis (See: Culture of
primary fibroblasts and keratinocytes) were homogenized in PBS
with proteinase inhibitors (Sigma). Protein content was determined
using the BCA method according to the manufacturers’ instructions
(Pierce Biotechnology, Rockford, IL). Protein concentration was
adjusted to 5mg/ml and wound lysate from three different animals/
genotype were pooled. Twenty-five micrograms protein lysate was
separated by SDS-PAGE using either 10% or 3–8% gradient gels.
Proteins were transferred onto nitrocellulose membranes. Mem-
branes were subsequently blocked in 1% BSA, 5% nonfat milk in
10 mM Tris-HCl/150 mM NaCl/0.05% Tween, followed by incubation
with primary antibodies directed against a-SMA (clone 1A4, Sigma),
integrin a2 (peptide synthesis, conjugation to keyhole limpet
hemocyanin and immunization were performed at Innovagen, Lund,
Sweden), integrin a11 (Dr Gullberg), integrin b1 (9EG7, BD
Biosciences), or vascular endothelial growth factor (VEGF, sc-152,
Santa Cruz Biotechnology, Santa Cruz, CA). Following incubation
with horseradish peroxides-conjugated secondary antibodies mem-
branes were developed using an enhanced chemiluminescence
detection system.
RNA isolation and reverse transcriptase-PCR
Total RNA was isolated from homogenized snap-frozen wound
tissue, lysed keratinocyte- and fibroblast cultures and enzymatically
separated dermis and epidermis using the RNeasy columns (Qiagen,
Hilden, Germany). Residual genomic DNA was removed by RNase-
free DNase I (Qiagen). One microgram of total RNA was reverse
transcribed in 25 ml with Superscript II (Invitrogen). For semiquanti-
tative PCR, 1 ml of the cDNA reaction was amplified using the Fast
Start DNA Polymerase Kit (Roche, Mannheim, Germany) with
primers and reaction conditions for integrin a1, a2, a10, and a11 as
described (Popova et al., 2004). Murine S26 RNA was used as
internal reference with forward primers 50-aat gtg cag ccc att cgc tgc-
30 and reverse primers 50-tgc ttc aga tat gtc cct gac-30; 28 cycles of
30 seconds 951C, 45 seconds 551C, and 60 seconds 721C.
Protein array
The expression of angiogenic factors in excisional wounds was
determined using a cytokine protein array (RayBiotech, Nordcross,
GA), according to the manufacturer’s instructions. Briefly, mem-
branes were blocked in blocking buffer for 30 minutes. One
milligram of wound lysate was incubated overnight at 41C on the
membrane, followed by incubation with a biotin-conjugated
cytokine antibody mix. After washing, expression of angiogenic
factors was visualized by incubation with HRP-conjugated strept-
avidin and subsequent enhanced chemiluminescence detection.
Biomechanics and collagen content determination
Breaking strength of strips of skin cut perpendicular to the axis of
incisional wounds was measured using a tensiometer (Model 3500,
Instron, Norwood, MA). Data were analyzed for breaking strength,
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elastic modulus, breaking energy, and tensile strain using BluehillTM
software (Instron). Part of the incisional wound was used to
determine total protein, using Bradford’s method. Amino-acid
composition of 6N HCl-hydrolyzed tissue specimens was deter-
mined by phenylisothiocyanate derivatization and reverse phase
high-performance liquid chromatography, as previously described
(Buckley et al., 1988). Percentage collagen content was calculated
from a formula based upon the relative hydroxyproline and proline
contents of collagenous and noncollagenous proteins.
Statistical procedures
Student’s t-test was used for comparison of means between groups.
A value of Po0.05 was considered significant.
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